Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2005
11/10/2005US20050250183 In vivo incorporation of unnatural amino acids
11/10/2005US20050250182 Novel genes, compositions, and methods for modulating the unfolded protein response
11/10/2005US20050250181 Cell-wall degrading enzyme variants
11/10/2005US20050250180 Secreted protein and polynucleotides encoding them
11/10/2005US20050250167 Purified pkb ser 473 kinase and uses thereof
11/10/2005US20050250166 Cdc7-ask kinase complex, substrates of the kinase complex, antibody specific to the substrate, and method of screening compound capable of inhibiting cdc7-ask kinase using the same
11/10/2005US20050250160 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
11/10/2005US20050250155 Multiple marker characterization of single cells
11/10/2005US20050250154 Peptides associated with hepsin protease active site for use in identification of modulators for treatment of cell proliferative disorders
11/10/2005US20050250153 Novel fetal genes
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050250149 Proteinase inhibitor, precursor thereof and genetic sequences encoding same
11/10/2005US20050250144 Novel genes encoding protein kinase/protein phosphatase
11/10/2005US20050250139 Member for producing a probe array and probe array producing method
11/10/2005US20050250136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/10/2005US20050250135 Nucleic acid encoding a polypeptide having histidine kinase activity; plasmids and host cells; engineering microorganisms, including Lactobacillus acidophilus, to have an increased ability to tolerate various stress conditions; probiotics
11/10/2005US20050250133 Molecular interaction sites of 16S ribosomal RNA and methods of modulating the same
11/10/2005US20050250128 Membranes incorporating recognition moieties
11/10/2005US20050250127 Methods for identifying modulators of MDA-7 mediated apoptosis
11/10/2005US20050250124 Methods of storing, aligning, and retrieving haplotype data
11/10/2005US20050250123 Reducing galectin-12 activity to reduce formation of adipocytes
11/10/2005US20050250120 Deleted sequences in M. bovis BCG/M bovis or M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
11/10/2005US20050250119 Fluorescent nucleobase conjugates having anionic linkers
11/10/2005US20050250110 PNA conjugate for treating chronic myeloid leukemia (CML)
11/10/2005US20050250107 High speed detection, isolation of cells; binding to antibodies; fluorescence classification; purification of antibody from egg yolk
11/10/2005US20050250106 Gene knock-down by intracellular expression of aptamers
11/10/2005US20050250105 Multiple viral replicon culture systems
11/10/2005US20050250104 Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based DNA library. application to the detection of mycobacteria
11/10/2005US20050250102 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
11/10/2005US20050250100 Method of utilizing the 5'end of transcribed nucleic acid regions for cloning and analysis
11/10/2005US20050250099 Direct pcr quantification
11/10/2005US20050250094 Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
11/10/2005US20050250093 Hepatitis c virus sub-genomic replicons
11/10/2005US20050250092 Providing an amplification primer mixture and amplifying the human papillomavirus genotypes
11/10/2005US20050249789 Alpha/beta hydrolase-fold enzymes
11/10/2005US20050249755 Mutant strains of Brucella melitensis and immunogenic compositions
11/10/2005US20050249754 CD4+ T-lymphocyte-specific hepatitis C virus epitopes
11/10/2005US20050249753 Hepatitis B virus (HBV); cDNA encoding said variable region; vectors and transformed cells; use to develop monoclonal antibodies for immunotherapy or diagnosis; A transformant E. coli DH5 alpha /YRC-pCRA9Hv (KCTC 1010BP)
11/10/2005US20050249752 Vector for anti-hpv vaccine and transformed microorganism by the vector
11/10/2005US20050249748 Polypeptides; antigens; vaccines; fusion protein containing signal peptide and polypeptide; genetic engineered Listeria bacteria
11/10/2005US20050249747 Recombinant high molecular weight major outer membrane protein of Moraxella
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249741 Novel Semaphorin gene: Semaphorin W
11/10/2005US20050249738 Immunotoxins directed against malignant cells
11/10/2005US20050249737 Dendritic cell potentiation
11/10/2005US20050249736 Polypeptide compounds for inhibiting angiogenesis and tumor growth
11/10/2005US20050249734 Cortistatin: neuropeptides, compositions and methods
11/10/2005US20050249731 Methods of implating mesenchymal stem cells for tissue repair and formation
11/10/2005US20050249729 Anti-TRAIL-R antibody
11/10/2005US20050249728 Anti-IGF-I receptor antibody
11/10/2005US20050249727 Prevention and treatment of amyloidogenic disease
11/10/2005US20050249725 Improving cognitive function of individuals with beta amyloid disfunction utilizing beta amyloid specific immunoglobulin; immunotherapeutics
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249706 Using transgenic and attenuated salmonella comprising tumor modulatory proteins and pharmceutical conjugate to treat cell proliferative disorders; targeted tissue therapy
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050247001 Building block forming a c-c or a c-hetero atom bond uponreaction
11/10/2005DE102004019803A1 Process to purify a soluble MHC protein in which the recombined product is soluble and not truncated
11/10/2005CA2565633A1 Lipids, lipid complexes and use thereof
11/10/2005CA2565125A1 Methods for reducing or eliminating alpha-mannosidase resistant glycans in the production of glycoproteins
11/10/2005CA2564831A1 Method of forming disulfide crosslink in in vitro protein synthesis
11/10/2005CA2564807A1 Methods and materials for improving plant drought tolerance
11/10/2005CA2564525A1 Ion channel
11/10/2005CA2564513A1 I-dmoi derivatives with enhanced activity at 37·c and use thereof
11/10/2005CA2564432A1 Human anti-amyloid .beta. peptide antibody and fragment of said antibody
11/10/2005CA2564131A1 Novel therapeutic targets in cancer
11/10/2005CA2563903A1 Process for preparing dipeptidyl iv inhibitors and intermediates therefor
11/10/2005CA2563176A1 Improved modulators of coagulation factors
11/10/2005CA2563064A1 Transgenic animals and uses thereof
11/10/2005CA2562893A1 Polyvalent viral vectors and a system for production thereof
11/10/2005CA2559809A1 Antibodies against human g-protein chemokine receptor (ccr5) hdgnr10
11/10/2005CA2557532A1 Inhibition of hairless protein mrna
11/10/2005CA2551842A1 Method of identifying hairpin dna probes by partial fold analysis
11/09/2005EP1593967A2 Composite arrays utilising microspheres
11/09/2005EP1593742A2 Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection
11/09/2005EP1593741A1 Method for producing extra-chromosomal nucleic acid molecules
11/09/2005EP1593740A1 Method of screening anti-obestic medicine, and obesity model animal
11/09/2005EP1593738A1 Virus-like particle vaccine containing dengue virus recombinant replicon as its carrier
11/09/2005EP1593425A1 Preparation method and use of micro-arrays supports for detection of multiple polynucleotide sequences with high sensitivity
11/09/2005EP1592970A2 Stimuli-responsive polymer conjugates and related methods
11/09/2005EP1592808A2 Single nucleotide polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy
11/09/2005EP1592799A2 Annexin and p34 promoters and use in expression of transgenic genes in plants
11/09/2005EP1592798A2 Cotton event mon 88913 and compositions and methods for detection thereof
11/09/2005EP1592797A1 Mevalonate kinase as a target for fungicides
11/09/2005EP1592796A2 Helminth-derived antigens having capacity of providing protection against parasites
11/09/2005EP1592795A2 Oligomeric compounds for the modulation of ras expression
11/09/2005EP1592794A2 Oligomeric compounds for the modulation of thioredoxin expression
11/09/2005EP1592793A2 Oligomeric compounds for the modulation of survivin expression
11/09/2005EP1592792A1 Proteomic screen to identify disease-related biological molecules and inhibitors thereto
11/09/2005EP1592791A2 Regulation of gene expression by dna interference
11/09/2005EP1592790A2 Electromagnetic activation of gene expression and cell growth
11/09/2005EP1592789A2 Administration of transposon-based vectors to reproductive organs
11/09/2005EP1592787A2 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE
11/09/2005EP1592784A1 Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms, and the use of the same
11/09/2005EP1592783A2 Method for producing carotenoids or their precursors using genetically modified organisms of the blakeslea genus, carotenoids or their precursors produced by said method and use thereof
11/09/2005EP1592780A2 Dyrks as modifiers of the apc and axin pathways and methods of use
11/09/2005EP1592773A2 Exogenous proteins expressed in avians and their eggs
11/09/2005EP1592713A2 Antibodies to c-met for the treatment of cancers
11/09/2005EP1592712A2 Anti-dengue virus antibodies, compositions, methods and uses
1 ... 1915 1916 1917 1918 1919 1920 1921 1922 1923 1924 1925 1926 1927 1928 1929 1930 1931 1932 1933 1934 1935 ... 4023